Response to letter entitled: Re: Oral cavity adjuvant therapy (OCAT) - a phase III, randomised controlled trial of surgery followed by conventional radiotherapy (5 fr/wk) versus concurrent CT-RT versus accelerated radiotherapy (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity.
Eur J Cancer
; 189: 112922, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-37321931
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Squamous Cell
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Eur J Cancer
Year:
2023
Document type:
Article